These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25139063)

  • 1. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans.
    Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK
    Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission.
    Prossin A; Koch A; Campbell P; Laumet G; Stohler CS; Dantzer R; Zubieta JK
    Mol Psychiatry; 2022 Feb; 27(2):831-839. PubMed ID: 34716408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute experimental changes in mood state regulate immune function in relation to central opioid neurotransmission: a model of human CNS-peripheral inflammatory interaction.
    Prossin AR; Koch AE; Campbell PL; Barichello T; Zalcman SS; Zubieta JK
    Mol Psychiatry; 2016 Feb; 21(2):243-51. PubMed ID: 26283642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.
    Kennedy SE; Koeppe RA; Young EA; Zubieta JK
    Arch Gen Psychiatry; 2006 Nov; 63(11):1199-208. PubMed ID: 17088500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.
    Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK
    Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans.
    Love TM; Stohler CS; Zubieta JK
    Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain activation of human supraspinal opioid pathways as demonstrated by [11C]-carfentanil and positron emission tomography (PET).
    Bencherif B; Fuchs PN; Sheth R; Dannals RF; Campbell JN; Frost JJ
    Pain; 2002 Oct; 99(3):589-598. PubMed ID: 12406535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
    Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
    Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of plasma interleukin-18 levels with emotion regulation and μ-opioid neurotransmitter function in major depression and healthy volunteers.
    Prossin AR; Koch AE; Campbell PL; McInnis MG; Zalcman SS; Zubieta JK
    Biol Psychiatry; 2011 Apr; 69(8):808-12. PubMed ID: 21145535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo effects on human mu-opioid activity during pain.
    Wager TD; Scott DJ; Zubieta JK
    Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal μ-opioid receptor availability in the amygdala predicts the inhibition of pain-related brain activity during heterotopic noxious counter-stimulation.
    Piché M; Watanabe N; Sakata M; Oda K; Toyohara J; Ishii K; Ishiwata K; Hotta H
    Neurosci Res; 2014; 81-82():78-84. PubMed ID: 24583336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of regional endogenous opioid function in borderline personality disorder.
    Prossin AR; Love TM; Koeppe RA; Zubieta JK; Silk KR
    Am J Psychiatry; 2010 Aug; 167(8):925-33. PubMed ID: 20439388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping neurotransmitter networks with PET: an example on serotonin and opioid systems.
    Tuominen L; Nummenmaa L; Keltikangas-Järvinen L; Raitakari O; Hietala J
    Hum Brain Mapp; 2014 May; 35(5):1875-84. PubMed ID: 23671038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: a PET study using [(11)C]carfentanil.
    Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Raitakari O; Keltikangas-Järvinen L; Hietala J
    Neuroimage; 2012 Jul; 61(3):670-6. PubMed ID: 22484309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.
    Hagelberg N; Aalto S; Tuominen L; Pesonen U; Någren K; Hietala J; Scheinin H; Pertovaara A; Martikainen IK
    Neurosci Lett; 2012 Jul; 521(1):11-4. PubMed ID: 22622175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women.
    Smith YR; Stohler CS; Nichols TE; Bueller JA; Koeppe RA; Zubieta JK
    J Neurosci; 2006 May; 26(21):5777-85. PubMed ID: 16723535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission.
    Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA
    Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender and age influences on human brain mu-opioid receptor binding measured by PET.
    Zubieta JK; Dannals RF; Frost JJ
    Am J Psychiatry; 1999 Jun; 156(6):842-8. PubMed ID: 10360121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interindividual variability and lateralization of μ-opioid receptors in the human brain.
    Kantonen T; Karjalainen T; Isojärvi J; Nuutila P; Tuisku J; Rinne J; Hietala J; Kaasinen V; Kalliokoski K; Scheinin H; Hirvonen J; Vehtari A; Nummenmaa L
    Neuroimage; 2020 Aug; 217():116922. PubMed ID: 32407992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in endogenous opioid functional measures in chronic back pain.
    Martikainen IK; Peciña M; Love TM; Nuechterlein EB; Cummiford CM; Green CR; Harris RE; Stohler CS; Zubieta JK
    J Neurosci; 2013 Sep; 33(37):14729-37. PubMed ID: 24027273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.